Author:
Dodwell David,Vergote Ignace
Subject
Radiology, Nuclear Medicine and imaging,Oncology,General Medicine
Reference25 articles.
1. Endocrine therapy in the treatment of metastatic breast cancer;Buzdar;Semin Oncol,2001
2. Comparison of the short-term biological effects of 7alpha-[9-(4,4,5,5,5- pentafluoropentylsulfinyl)-nonyl]estra-1,3,5,(10)-triene-3,17beta-diol (Faslodex) versus tamoxifen in postmenopausal women with primary breast cancer;Robertson;Cancer Res,2001
3. Fulvestrant Faslodex® in metastatic breast cancer;Steger;Breast Cancer Res Treat,2003
4. Fulvestrant, formerly ICI 182,780, is as effective as anastrozole in postmenopausal women with advanced breast cancer progressing after prior endocrine treatment;Howell;J Clin Oncol,2002
5. Double-blind, randomized trial comparing the efficacy and tolerability of fulvestrant versus anastrozole in postmenopausal women with advanced breast cancer progressing on prior endocrine therapy: results of a North American trial;Osborne;J Clin Oncol,2002
Cited by
23 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献